about
Incorporated in 1978, Biocon is engaged in the manufacture of biotechnology products and research services. The company's business include Generics with diverse portfolio encompasses a wide range of complex molecules, including cardiovascular medicat...
Read More
351.85
2.45
(0.70%)
4.5M
NSE+BSE Volume
NSE 14 Oct, 2025 3:31 PM (IST)
US FDA Observation
Biocon's New Jersey manufacturing facility receives Form 483 with one observation from the US FDA
See details